4.8 Article

FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans

期刊

CELL METABOLISM
卷 25, 期 5, 页码 1045-+

出版社

CELL PRESS
DOI: 10.1016/j.cmet.2017.04.009

关键词

-

资金

  1. Danish Council for Independent Research [4092-00240B]
  2. Tripartite Immunometabolism Consortium (TrIC)- Novo Nordisk Foundation [NNF15CC0018486]
  3. Novo scholarship
  4. Rigshospitalets Forskningsfund
  5. Novo Nordisk Foundation Center for Basic Metabolic Research
  6. TrygFonden
  7. Danish National Research Foundation [DNRF55]
  8. Danish Council for Strategic Research [09 - 067009, 09 - 075724]
  9. Novo Nordisk Foundation
  10. NNF Center for Basic Metabolic Research [Gillum Group] Funding Source: researchfish
  11. Novo Nordisk Fonden [NNF15SA0018486, NNF14OC0009525] Funding Source: researchfish

向作者/读者索取更多资源

The liking and selective ingestion of palatable foods-including sweets-is biologically controlled, and dysfunction of this regulation may promote unhealthy eating, obesity, and disease. The hepatokine fibroblast growth factor 21 (FGF21) reduces sweet consumption in rodents and primates, whereas knockout of Fgf21 increases sugar consumption in mice. To investigate the relevance of these findings in humans, we genotyped variants in the FGF21 locus in participants from the Danish Inter99 cohort (n = 6,514) and examined their relationship with a detailed range of food and ingestive behaviors. This revealed statistically significant associations between FGF21 rs838133 and increased consumption of candy, as well as nominal associations with increased alcohol intake and daily smoking. Moreover, in a separate clinical study, plasma FGF21 levels increased acutely after oral sucrose ingestion and were elevated in fasted sweet-disliking individuals. These data suggest the liver may secrete hormones that influence eating behavior.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据